SUBSCRIBE
SUBSCRIBE
News   FDA

Australian Agency Approves Sandoz Recombinant DNA Human Growth Hormone Omnitrope

October 19, 2005 | 
1 min read
Sandoz has received approval from the Australian Therapeutic Goods Administration (TGA) to market the recombinant DNA human growth hormone Omnitrope. The TGA has recognized the safety and efficacy of Omnitrope by approving the product.
FDA Approvals
MORE ON THIS TOPIC
3D Isometric Flat Vector Illustration of Expensive Unaffordable Drugs, Health Care Costs
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
 · 
5 min read
 · 
Annalee Armstrong
Handshake of man and robot. Modern technologies. Art collage.
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
May 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
FDA Delays Continue as Regulator Misses Review Date for GSK’s Nucala
May 9, 2025
 · 
2 min read
 · 
Tristan Manalac
illustration of the ship in the storm, gigantic waves
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
May 9, 2025
 · 
2 min read
 · 
Annalee Armstrong